Insurance Collaboration Partner with large insurers and risk consultants to quantify the clinical and financial impact of IV infiltration injuries, creating a clear ROI case that accelerates payer adoption and coverage for ivWatch technology.

Healthcare Expansion Target hospitals and health systems with high IV usage and patient throughput in acute care, infusion centers, and oncology clinics where early detection of infiltrations reduces complications, length of stay, and liability.

Clinical Evidence Leverage the recent collaboration with Aon and ongoing safety data to build robust case studies and economic models that demonstrate cost savings and risk reduction to hospital procurement teams.

Strategic Partnerships Engage with patient safety and clinical leadership personas, including risk managers, CNOs, and infusion service directors, to position ivWatch as a standard of care for IV therapy safety.

Brand Credibility Highlight FDA-cleared and CE-marked status, awards, and industry recognition to differentiate from competitors and support pilot programs, accelerating adoption in mid-market to enterprise accounts.